Jump to content

Biden to launch COVID-19 task force, Trump plans rallies to protest election


Recommended Posts

Posted

Breaking news:  The U.S. FDA  grants Eli Lilly emergency authorization to use its novel monoclonal antibody drug bamlanivimab to fight COVID-19.

 

U.S. allows emergency use of first COVID-19 antibody drug

 

Lilly announces agreement with U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555)  to fight COVID-19

 

Lilly has leveraged our deep scientific capability to fight this pandemic and we are proud of our efforts to develop potential medicines to combat COVID-19. Supply agreements with governments – such as this one with the U.S. government to meet Operation Warp Speed goals.

  • Like 1
  • Thanks 1
Posted
3 minutes ago, rabas said:

Breaking news:  The U.S. FDA  grants Eli Lilly emergency authorization to use its novel monoclonal antibody drug bamlanivimab to fight COVID-19.

 

U.S. allows emergency use of first COVID-19 antibody drug

 

Lilly announces agreement with U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555)  to fight COVID-19

 

Lilly has leveraged our deep scientific capability to fight this pandemic and we are proud of our efforts to develop potential medicines to combat COVID-19. Supply agreements with governments – such as this one with the U.S. government to meet Operation Warp Speed goals.

You keep proving yourself wrong. Pfizer did not receive funding nor was it part of warp speed.

  • Like 2
Posted
15 minutes ago, rabas said:

Breaking news:  The U.S. FDA  grants Eli Lilly emergency authorization to use its novel monoclonal antibody drug bamlanivimab to fight COVID-19.

 

U.S. allows emergency use of first COVID-19 antibody drug

 

Lilly announces agreement with U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555)  to fight COVID-19

 

Lilly has leveraged our deep scientific capability to fight this pandemic and we are proud of our efforts to develop potential medicines to combat COVID-19. Supply agreements with governments – such as this one with the U.S. government to meet Operation Warp Speed goals.

Just to add to your information that FDA has issued EUAs to 50 serology tests which also detect antibodies including from Singapore. Anyway it is good to see efforts to develop potential medicine for covid-19. No one should take credit for the good of mankind.

https://www.straitstimes.com/singapore/health/singapore-teams-covid-19-neutralising-antibody-test-kit-is-first-to-get-us-fda?utm_source=emarsys&utm_medium=email&utm_campaign=ST_Newsletter_PM&utm_term=Singapore+team's+Covid-19+neutralising+antibody+test+kit+is+first+to+get+US+FDA+approval&utm_content=09%2F11%2F2020

  • Thanks 1
Posted
2 hours ago, Sujo said:

So you are incorrect. Its still n the r and d stage and they have had no assistance from the govt. they are not part of warp speed.

 

when its all approved then the govt will assist. 

Assist actually meaning place an order to buy.

Posted
3 hours ago, rabas said:

 

My links are from "Genetic Engineering and Biotechnology News" and the HHS.gov website. And you call it mis-information !  She is talking about R&D dollars only. Not the $2 billion contract and assistance for manufacturing and distribution.

 

Horse meets trough, won't drink.

I assume that contract yields no gains for Pfizer until and if they develop a vaccine and need to manufacture and distribute it. 

If true then Trump benefitted immediately with  PR move and Pfizer us still fronting the money and doing the work. Wouldn't that qualify as fake news? 

 

It's kinda like pretending to be friends with the cool guys in high school so the girls will like you. It didn't work well in high school either. 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...